PH027
/ Suzhou Puhe Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 06, 2024
PH027-1, a potent and selective small-molecule WRN inhibitor that targets MSI-H tumors
(AACR 2024)
- "As a highly selective and potent inhibitor on helicase activity of WRN, PH027-1 has the potential to become a novel and safe approach for treatment of MSI-H tumors."
Colorectal Cancer • Gastrointestinal Cancer • Microsatellite Instability • Oncology • Ovarian Cancer • Solid Tumor • CD34 • MSI • RECQL4 • RECQL5 • WRN
1 to 1
Of
1
Go to page
1